Q1 2019 Enanta Pharmaceuticals Inc Earnings Call Transcript
Good day. My name is Ian, and I will be your conference operator today.
At this time, I would like to welcome everyone to the Enanta Pharmaceuticals First Quarter Financial Results Conference Call. (Operator Instructions)
I'd now like to turn the call over to Carol Miceli. Ma'am, you may begin.
Thank you, Ian, and thanks for joining us this afternoon. The news release with our financial results for the recent quarter was issued and is available on our website.
On the call today is Dr. Jay Luly, President and Chief Executive Officer; Paul Mellett, our Chief Financial Officer; and other members of Enanta's senior management team.
But before we begin with our formal remarks, we want to remind you that we will be making forward-looking statements, which may include our plans and expectations with respect to our product candidates and financial projections, all of which involve certain assumptions and risks beyond our control that could cause our actual developments
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |